Vassilena Tsvetkova
Verona, 37134, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms of the Pancreas.
Journal: Surgical pathology clinics
Published: September 01, 2022
New insights in gastrointestinal "pediatric" neoplasms in adult patients: pancreatoblastoma, hepatoblastoma and embryonal sarcoma of the liver. A practical approach by GIPPI-GIPAD Groups.
Journal: Pathologica
Published: February 25, 2022
Ki67/MART1 and p63/SOX10 Dual Immunohistochemistry Allows a Correct Interpretation of the Melanocytic Component in the Diagnosis of Pigmented Pilomatricoma.
Journal: Indian journal of dermatology
Published: January 24, 2022
Molecular Analysis of an Intestinal Neuroendocrine/Non-neuroendocrine Neoplasm (MiNEN) Reveals MLH1 Methylation-driven Microsatellite Instability and a Monoclonal Origin: Diagnostic and Clinical Implications.
Journal: Applied immunohistochemistry & molecular morphology : AIMM
Published: April 28, 2021
Impact of estrogen receptor levels on outcome in non-metastatic triple negative breast cancer patients treated with neoadjuvant/adjuvant chemotherapy.
Journal: NPJ breast cancer
Published: December 04, 2020
Axillary Hibernoma in woman with Lobular breast cancer and MEN1 syndrome: A case report.
Journal: International journal of surgery case reports
Published: August 12, 2020
Integration of tumour infiltrating lymphocytes, programmed cell-death ligand-1, CD8 and FOXP3 in prognostic models for triple-negative breast cancer: Analysis of 244 stage I-III patients treated with standard therapy.
Journal: European journal of cancer (Oxford, England : 1990)
Published: February 28, 2020
Papilloma virus infection in oral malignancies: An Italian experience.
Journal: Indian journal of cancer
Published: August 08, 2019
Androgen Receptor Expression and Association With Distant Disease-Free Survival in Triple Negative Breast Cancer: Analysis of 263 Patients Treated With Standard Therapy for Stage I-III Disease.
Journal: Frontiers in oncology
Published: January 24, 2019
Last Updated: 09/26/2026